Found 231 matching trials
Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia PHASE2 Phase II study to evaluate safety and efficacy of DCP-001 in patients with ...
Show More Location
Helsinki University Hospital
Learn More & Join Trial
The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT EARLY_PHASE1 The purpose of this study is to evaluate the efficacy and safety of allogen...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
Study to Assess an Interphase Cycle With Flotetuzumab. PHASE2 Patients who have measurable residual disease (MRDpos, defined as MRD \> 0....
Show More Location
NL-Amsterdam-VUMC
Learn More & Join Trial
Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia PHASE1 This is a phase 1, first-in-human (FIH), open-label, multicohort study to e...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS PHASE1 This is a first-in-human dose escalation/dose expansion study to evaluate t...
Show More Status
Active Not Recruiting
Location
H Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
Monitoring Minimal Residual Disease(MRD)in Pediatric B-acute Lymphoblastic Leukemia N/A This study aimed to investigate the performance of next-generation sequenci...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML PHASE3 MRD driven study. Addition of gemtuzumab to conventional chemotherapy to re...
Show More Location
A.O. - SS. Antonio e Biagio e Cesare Arrigo - SC Ematologia
Learn More & Join Trial
Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial NA The goal of this interventional clinical trial is to compare the efficacy o...
Show More Location
Multiple Locations
Learn More & Join Trial
Bugitinib Combined With Venetoclax and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia PHASE2 This is a prospective, single-arm, exploratory study evaluating the combina...
Show More Location
Shenzhen University general hospital
Learn More & Join Trial
Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC N/A Multi-center observational clinical study to evaluate the application value...
Show More Location
Parc de Salut Mar - Hospital del Mar
Learn More & Join Trial